Products Categories
| CAS No.: | 132-22-9 |
|---|---|
| Name: | Chloropheniramine-d4 |
| Molecular Structure: | |
|
|
|
| Formula: | C16H19 Cl N2 |
| Molecular Weight: | 274.793 |
| Synonyms: | Pyridine,2-[p-chloro-a-[2-(dimethylamino)ethyl]benzyl]-(8CI); (?à)-Chloropheniramine; (?à)-Chlorpheniramine;1-(p-Chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane; 2-[p-Chloro-a-[2-(dimethylamino)ethyl]benzyl]pyridine;3-(p-Chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine; 4-Chloropheniramine;Allergican; Chloropheniramine; Chlorophenylpyridamine; Chloroprophenpyridamine;Chlorphenamine; Chlorpheniramine; Chlorprophenpyridamine; Haynon;RS-Chlorpheniramine;dl-1-(p-Chlorophenyl)-1-(2-pyridyl)-3-(dimethylamino)propane; g-(4-Chlorophenyl)-g-(2-pyridyl)propyldimethylamine |
| Density: | 1.107g/cm3 |
| Melting Point: | 25°C |
| Boiling Point: | 379°Cat760mmHg |
| Flash Point: | 183°C |
| Solubility: | 5.496g/L(37.5 oC) |
| Safety: | Poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. When heated to decomposition it emits toxic vapors of NOx and Cl−. |
| PSA: | 16.13000 |
| LogP: | 3.81860 |

| Conditions | Yield |
|---|---|
| With hydrogen; platinum(IV) oxide In toluene at 120℃; under 38000 Torr; for 12h; catalytic reductive amination; | 100% |

chloropheniramine nitrile


Chlorpheniramine

| Conditions | Yield |
|---|---|
| With potassium hydroxide at 160℃; for 4h; | 95% |

3-(4-chlorophenyl)-3-pyridin-2-yl-propan-1-ol


dimethyl amine


Chlorpheniramine

| Conditions | Yield |
|---|---|
| With [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2; bis[2-(diphenylphosphino)phenyl] ether In toluene at 20℃; Inert atmosphere; Reflux; | 81% |

| Conditions | Yield |
|---|---|
| (η5-cyclopentadienyl)-η4-cycloocta-1,5-dienecobalt(I) In toluene at 140℃; under 10640 Torr; for 36h; | 75% |

| Conditions | Yield |
|---|---|
| With diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; 0.8C12H6N2O4(2-)*HO(1-)*Al(3+)*0.4CF3O3S(1-)*0.1Ir(3+)*0.2C11H8N(1-)*0.1Cl(1-) In acetonitrile at 20℃; for 6h; Inert atmosphere; Irradiation; | 36% |

| Conditions | Yield |
|---|---|
| With sodium amide; benzene anschl. mit <2-Chlor-aethyl>-dimethyl-amin und anschl. Erhitzen mit wss. H2SO4; | |
| With sodium amide; benzene anschl. mit <2-Chlor-aethyl>-dimethyl-amin und anschl. Erhitzen mit NaOH in Butan-1-ol; |

| Conditions | Yield |
|---|---|
| With potassium amide | |
| With sodium amide | |
| Stage #1: 2-(4-chlorobenzyl)pyridine With sodium amide In tetrahydrofuran at 20 - 25℃; for 1h; Stage #2: 2-(dimethylamino)ethyl chloride In tetrahydrofuran; toluene at 30 - 45℃; for 2h; |

| Conditions | Yield |
|---|---|
| With 2-pyridyllithium; diethyl ether |

1t-(4-chloro-phenyl)-3-dimethylamino-1c-[2]pyridyl-propene


Chlorpheniramine

| Conditions | Yield |
|---|---|
| With palladium on activated charcoal; acetic acid Hydrogenation; |


Chlorpheniramine

| Conditions | Yield |
|---|---|
| With sulfuric acid; water |
Chemistry informtion about Chlorpheniramine (CAS NO.132-22-9) is:
IUPAC Name: 3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
Synonyms: Chlorpheniramine ; Dl-Chlorpheniramine
MF: C16H19ClN2
MW: 274.79
Density: 1.107 g/cm3
Flash Point: 183 °C
Boiling Point: 379 °C at 760 mmHg
Enthalpy of Vaporization: 62.7 kJ/mol
Vapour Pressure: 6.04E-06 mmHg at 25°C
Following is the molecular structure of Chlorpheniramine (CAS NO.132-22-9) is:

Chlorpheniramine (CAS NO.132-22-9) is often combined with phenylpropanolamine to form an allergy medication with both antihistamine and decongestant properties.
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 125mg/kg (125mg/kg) | Yakugaku Zasshi. Journal of Pharmacy. Vol. 92, Pg. 1339, 1972. | |
| mouse | LD50 | intravenous | 20mg/kg (20mg/kg) | Medizinische Welt. Vol. 17, Pg. 2791, 1966. | |
| mouse | LD50 | oral | 121mg/kg (121mg/kg) | Medizinische Welt. Vol. 17, Pg. 2791, 1966. | |
| mouse | LD50 | subcutaneous | 160mg/kg (160mg/kg) | Bollettino Chimico Farmaceutico. Vol. 111, Pg. 293, 1972. | |
| rabbit | LD50 | intravenous | 22mg/kg (22mg/kg) | Medizinische Welt. Vol. 17, Pg. 2791, 1966. | |
| rat | LD50 | oral | 118mg/kg (118mg/kg) | Medizinische Welt. Vol. 17, Pg. 2791, 1966. |
Reported in EPA TSCA Inventory.
Poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. When heated to decomposition it emits toxic vapors of NOx and Cl−.